TY  - JOUR
T1  - SAline trial ended
AU  - Kuehn BM
Y1  - 2009/05/27
N1  - 10.1001/jama.2009.715
JO  - JAMA
SP  - 2085
EP  - 2085
VL  - 301
IS  - 20
N2  - 
Last August, when the trial's data and safety monitoring board found evidence that patients who received the concentrated saline were no more likely to survive than those who received a standard saline solution, it suspended enrollment in the trial. Patients in this study who received the concentrated solution were more likely to die in the emergency department or before reaching the hospital than were patients who received the standard saline solution. Both groups experienced a similar death rate during the 28-day period after treatment; however, deaths occurred later in the normal saline group.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2009.715
UR  - http://dx.doi.org/10.1001/jama.2009.715
ER  -